Spencer Todd

investor intelligence

MedTech's European Money Map: what investors are betting on in 2026.

A founder's guide to European investors funding medtech in 2026, what they back, and what they want to see before they write the cheque.

What Dovetail’s Envoy Service Is, Why It's Different, and Why It's Working

At Dovetail, we believe in human judgement alongside brilliant AI. AI has brought unbridled efficiency to our work and intelligence to our fingertips that was previously inaccessible. You could have it build any document with the right context. It’s enough to do just about anything. But not everything. It

Crossing the Atlantic? Four Things Every UK Medtech Founder Must Pack Before Facing the FDA.

America turns 250 this year. For UK medtech, the US market is still the market worth crossing an ocean for. Standing at the door to the US market is the FDA, and (surprise!) it works nothing like the MHRA or a Notified Body.

FormlyAI is now Dovetail.

Same team, same platform, new name. Our experts dovetail into your team, our platform dovetails into the tools you already use, and the device you've built reaches the people who need it most. That's why we're now Dovetail.

The FDA Q-Submission Process: A Medtech founder’s guide to the Pre-Sub

TL;DR A Q-Submission (most often a Pre-Sub) is a free, formal way to get FDA’s written feedback on your device and your submission plan before you file. You send a short package with specific questions, FDA responds in writing within about 75 days, and they usually

The AI Never Told Me: What the FDA's Warning Letter on AI Actually Means

A few weeks ago, the FDA sent a warning letter to Purolea Cosmetics Lab. It's been getting a lot of attention, mostly framed as a warning shot at AI in pharmaceutical manufacturing. "FDA says AI is a liability." That kind of thing. I want to offer

Breaking into the US Medtech Market: What Founders Need to Know About the FDA.

Compared to other regulatory authorities across the world, the FDA’s approach to regulations and engaging with companies looking to clear their medical devices is unique. The predicate system, enforcement discretion products, and the De Novo pathway, to name a few, are regulatory concepts that are unlike most other countries.

FormlyAI raises $2M led by Heal Capital to revolutionize medical device compliance using AI

New capital to accelerate US market expansion, scale EU operations, and further develop its AI-powered platform that has already saved clients an average of $70K and reduced time-to-market tenfold. CHARLESTON, September 11, 2025 – FormlyAI, the only AI-native solution for medical device certification, today announced the closure

How to Estimate Risk in Medical Devices According to ISO 14971

TL;DR If you're building a medical device, ISO 14971 is your blueprint for making sure it’s safe, and not just “we hope it doesn’t explode” safe. It's a structured way to think through what could go wrong, how bad that would be, how

Getting Started with Medical Device Risk: An Intro to ISO 14971

TL;DR If you're building a medical device, ISO 14971 is a necessity as it is your blueprint for safety. It’s a formal process for figuring out what could possibly go wrong (hazards and harms), so you can manage those risks before they ever reach a patient.

Why every medical device manufacturer should know their GSPRs

TL;DR (too lazy, didn’t read) Medical devices need to meet specific performance and safety requirements called GSPRs (General Safety and Performance Requirements) before they can be sold in Europe. Essentially it's like a super-detailed safety checklist that ensures medical devices are safe and work like

IEC 62304: Software development, the medical device version

TL;DR (too lazy, didn’t read) IEC 62304 is basically the rulebook for medical device software development. Whether you're creating a standalone medical app or software that's built into medical devices, this standard tells you how to do it safely and properly. The standard has